NPA vs. LCAP
Should you be buying New Providence Acquisition stock or one of its competitors? The main competitors of New Providence Acquisition include Lionheart Acquisition Co. II (LCAP).
Lionheart Acquisition Co. II (NASDAQ:LCAP) and New Providence Acquisition (NASDAQ:NPA) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their valuation, earnings, institutional ownership, media sentiment, profitability, dividends, risk, analyst recommendations and community ranking.
Lionheart Acquisition Co. II and New Providence Acquisition both received 0 outperform votes by MarketBeat users.
Lionheart Acquisition Co. II's return on equity of 0.00% beat New Providence Acquisition's return on equity.
63.9% of New Providence Acquisition shares are owned by institutional investors. 19.4% of Lionheart Acquisition Co. II shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.
In the previous week, New Providence Acquisition's average media sentiment score of 0.00 equaled Lionheart Acquisition Co. II'saverage media sentiment score.
Lionheart Acquisition Co. II has a beta of 0.08, suggesting that its stock price is 92% less volatile than the S&P 500. Comparatively, New Providence Acquisition has a beta of 0.2, suggesting that its stock price is 80% less volatile than the S&P 500.
Summary
Lionheart Acquisition Co. II and New Providence Acquisition tied by winning 3 of the 6 factors compared between the two stocks.
Get New Providence Acquisition News Delivered to You Automatically
Sign up to receive the latest news and ratings for NPA and its competitors with MarketBeat's FREE daily newsletter.
New Providence Acquisition Competitors List
Related Companies and Tools